All stocks Β· CAPRIHANS
CI

Caprihans India Ltd.

CAPRIHANS BSE Specialty Chemicals Basic Materials

Caprihans India Limited engages in the pharmaceutical packaging business in India and internationally. The company also manufactures and sells rigid and flexible polyvinyl chloride (PVC) films, polyvinylidene chloride (…

ISIN INE479A01018
Listed β€”
Quarters tracked 11
Filings 20 docs

About

Caprihans India Limited engages in the pharmaceutical packaging business in India and internationally. The company also manufactures and sells rigid and flexible polyvinyl chloride (PVC) films, polyvinylidene chloride (PVDC) coated films, plastic extruded products, alu alu foils, and other allied products. In addition, it provides thermoforming blister films under the Duplex, Triplex, Ultra, Ultra Tx, Armour, Aclar, Excel, Exxtra, Optra, BAPP, Zymax, Zymax Tx, and Zymax PDP names; coldforming blister foils under the Venus, Venus PR, Venus SBC, Tropical Foil, Nutra Venus, and Vento Venus names; lidding blister foils under the Zeon, Zeon+, Zenith, Zeon+PR, Suppo Zenith, Zeon PR, Zeon D, Zeon X, and DESALU names; lidding foils under the Crispak AP-PT, Crispak PL, Crispak PP, and Crispak PT names; and laminates/sachet foils under the Lamiflex PAL and RAL brand names. Further, the company offers pharma packaging research services, including formulation stability studies, blister / foil design and development, pharma brand innovation, analytical research and market study, and packaging trials and audit services. It exports its products. The company was incorporated in 1946 and is headquartered in Pune, India. Caprihans India Limited is a subsidiary of Bilcare Mauritius Limited.

Key Metrics

as of Sep 2026
Market Cap198 Cr
P/Eβ€”
Div Yield0.00 %
Book Valueβ‚Ή254.00
52w Highβ‚Ή144.00
52w Lowβ‚Ή50.30
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023
Sales 221.39 183.07 175.31 174.77 181.89 186.40 191.03 191.74 182.35 190.98 163.32
Expenses 187.56 165.13 163.41 173.27 172.59 179.75 183.37 185.27 166.92 195.91 146.04
Operating Profit 33.83 17.94 11.90 1.50 9.30 6.65 7.66 6.47 15.43 -4.93 17.28
OPM % 15.28 9.80 6.79 0.86 5.11 3.57 4.01 3.37 8.46 -2.58 10.58
Other Income 1.82 18.49 1.37 4.35 3.02 18.62 -6.41 -6.02 3.82 5.06 3.74
Depreciation 10.76 11.14 11.27 11.56 10.93 11.03 11.02 10.35 10.80 12.81 10.05
Interest 18.67 18.25 17.56 19.57 19.05 19.26 20.14 21.43 20.97 21.81 21.08
Profit before tax 6.22 7.04 -15.56 -25.28 -17.66 -5.02 -29.91 -31.33 -12.52 -34.49 -10.11
Tax % 0.00 0.00 0.26 -1.54 -23.22 -145.02 -37.95 -9.48 40.65 -48.07 34.92
Net Profit 6.22 7.04 -15.60 -24.89 -13.56 2.26 -18.56 -28.36 -17.61 -17.91 -13.64
EPS in Rs 3.53 4.42 -10.67 -17.02 -9.27 1.55 -14.13 -21.59 -13.41 -13.64 -10.39

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024
Sales 715.00752.00704.00
Expenses 673.00716.00660.00
Operating Profit 42.0036.0044.00
OPM % 6.004.806.00
Other Income 26.0010.0016.00
Interest 74.0082.0083.00
Depreciation 45.0043.0043.00
Profit before tax -51.00-79.00-65.00
Tax % -9.00-21.00-21.00
Net Profit -47.00-62.00-52.00
EPS in Rs -29.53-42.52-39.30
Dividend Payout % 0.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024
Equity Capital 16.0015.0013.00
Reserves 388.00272.00290.00
Borrowings 642.00841.00960.00
Other Liabilities 139.00127.00154.00
Total Liabilities 1,185.001,254.001,417.00
Fixed Assets 854.00888.00976.00
CWIP 8.004.001.00
Investments 14.0011.008.00
Other Assets 308.00351.00433.00
Total Assets 1,185.001,254.001,417.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024
Cash from Operating Activity 121.0090.00-47.00
Cash from Investing Activity -8.0068.0010.00
Cash from Financing Activity -118.00-161.0037.00
Net Cash Flow -5.00-3.001.00
Free Cash Flow 112.00157.00-38.00
CFO/OP % 283.00257.00-103.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024
Debtor Days 53.0056.0080.00
Inventory Days 87.0082.0081.00
Days Payable 69.0057.0070.00
Cash Conversion Cycle 71.0082.0091.00
Working Capital Days 4.00-37.00-16.00
ROCE % 2.001.00β€”

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 55.99 55.99 55.99 55.99 54.75 51.00 51.00 51.00 51.00 51.00 51.00 51.00
DIIs 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Public 43.99 43.99 43.99 44.01 45.22 48.98 48.97 48.98 48.98 48.98 48.98 48.99
No. of Shareholders 6,846 6,857 7,131 7,349 7,365 7,421 7,737 7,718 7,694 7,661 7,504 7,431

Corporate Actions

17 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Other 31 Oct 2024 β€” β€” β€” E.G.M.
Other 17 Mar 2023 β€” β€” β€” E.G.M.
Dividend 12 Sep 2019 β€” β€” 0.75
Dividend 11 Sep 2018 β€” β€” 1.50
Dividend 14 Sep 2017 β€” β€” 1.50
Dividend 20 Sep 2016 β€” β€” 1.50
Dividend 14 Sep 2015 β€” β€” 1.50
Dividend 11 Sep 2014 β€” β€” 1.50
Dividend 22 Aug 2013 β€” β€” 1.50
Dividend 30 Aug 2012 β€” β€” 1.50
Dividend 12 Sep 2011 β€” β€” 1.50
Dividend 13 Sep 2010 β€” β€” 2.50
Dividend 03 Aug 2009 β€” β€” 1.50
Dividend 20 Aug 2008 β€” β€” 1.00
Dividend 10 Sep 2007 β€” β€” 1.00
Other 25 Apr 2001 β€” β€” β€” Agm
Other 15 Mar 2000 β€” β€” β€” Agm

Announcements

5 filings